Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.
Ann Hematol. 2017 Oct;96(10):1681-1691. doi: 10.1007/s00277-017-3061-3. Epub 2017 Jul 31.
Ann Hematol. 2017.
PMID: 28762081
Free PMC article.
Clinical Trial.
Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)-a single region experience on consecutive patients.
Eketorp Sylvan S, Lundin J, Ipek M, Palma M, Karlsson C, Hansson L.
Eketorp Sylvan S, et al.
Ann Hematol. 2014 Oct;93(10):1725-33. doi: 10.1007/s00277-014-2105-1. Epub 2014 May 21.
Ann Hematol. 2014.
PMID: 24844780
Item in Clipboard
Outcomes of patients with fludarabine-refractory chronic lymphocytic leukemia: a population-based study from a well-defined geographic region.
Eketorp Sylvan S, Hansson L, Karlsson C, Norin S, Lundin J, Osterborg A.
Eketorp Sylvan S, et al.
Leuk Lymphoma. 2014 Aug;55(8):1774-80. doi: 10.3109/10428194.2013.827786. Epub 2014 Feb 4.
Leuk Lymphoma. 2014.
PMID: 24237446
Item in Clipboard
Outcomes of second-line treatment in chronic lymphocytic leukemia - a population-based study from a well defined geographical region between 2003 and 2013.
Asklid A, Winqvist M, Eketorp Sylvan S, Mattsson A, Björgvinsson E, Søltoft F, Repits J, Diels J, Österborg A, Hansson L.
Asklid A, et al. Among authors: eketorp sylvan s.
Leuk Lymphoma. 2017 May;58(5):1219-1223. doi: 10.1080/10428194.2016.1246727. Epub 2016 Nov 28.
Leuk Lymphoma. 2017.
PMID: 27894205
No abstract available.
Item in Clipboard
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
Winqvist M, Mozaffari F, Palma M, Eketorp Sylvan S, Hansson L, Mellstedt H, Österborg A, Lundin J.
Winqvist M, et al. Among authors: eketorp sylvan s.
Cancer Immunol Immunother. 2017 Jan;66(1):91-102. doi: 10.1007/s00262-016-1922-6. Epub 2016 Nov 4.
Cancer Immunol Immunother. 2017.
PMID: 27815572
Free PMC article.
Clinical Trial.
Item in Clipboard
A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy.
Asklid A, Eketorp Sylvan S, Mattsson A, Winqvist M, Johansson H, Österborg A, Hansson L.
Asklid A, et al. Among authors: eketorp sylvan s.
Leuk Lymphoma. 2020 Sep;61(9):2136-2144. doi: 10.1080/10428194.2020.1765233. Epub 2020 May 25.
Leuk Lymphoma. 2020.
PMID: 32449636
Item in Clipboard
Cite
Cite